 |
8:00am - 9:00am
Department of Medicine Fellows Grand Rounds
Presentation 1 - TITLE:
Omalizumab: Targeting IgE in Chronic Idiopathic Urticaria
SPEAKER:
Emily Weis, MD
Allergy/Immunology Fellow
Division of Allergy, Immunology and Rheumatology
University of Rochester Medical Center
Biosketch
Educational Objectives:
At the conclusion of this presentation participants should be able to:
1. Understand that chronic idiopathic urticaria is often very difficult to treat, and many patients do not respond to second generation antihistamines.
2. Omalizumab has been shown to significantly decrease the symptoms associated with chronic idiopathic urticaria in patients who have failed anti-histamine therapy.
Presentation 2 - TITLE:
Tofacatinib: The Benefits and the Perils of Oral Small Molecule Inhibitors for RA
SPEAKER:
Joshua Weitz, MD
Combined Fellow
Division of Allergy, Immunology and Rheumatology
University of Rochester Medical Center
Biosketch
Educational Objectives:
At the conclusion of this presentation participants should be able to:
1. Identify the indications for tofacatinib.
2. Understand the risks/benefits/safety profile and ideal patient population for use of this medication.
|
| Location: | Class of 1962 Auditorium, Kornberg Medical Research Building |
Posted by: Mary Lou Beagan, Medicine, 11-Apr-13 6:22pm ET
|
